1 H-MR detection of NAD þ was achieved with a one-dimensional double-spin-echo method on a slice parallel to the surface coil transceiver. Perturbation of the water resonance was avoided through the use of frequency-selective excitation.
1 H-MR detection of NAD þ was achieved with a one-dimensional double-spin-echo method on a slice parallel to the surface coil transceiver. Perturbation of the water resonance was avoided through the use of frequency-selective excitation. 31 P-MR detection of NAD þ was performed with an unlocalized pulse-acquire sequence. H-MRS and 367 6 78 mM and 312 6 65 mM for 31 P-MRS when uridine diphosphate glucose (UDPG) was excluded and included, respectively, as an overlapping signal. Conclusions: NAD þ detection by 1 H-MRS is a simple method that comes at the price of reduced NMR visibility. NAD þ detection by 31 P-MRS has near-complete NMR visibility, but it is complicated by spectral overlap with NADH and UDPG. Overall, the 
INTRODUCTION
Nicotinamide adenine dinucleotide (NAD þ ) and its reduced form (NADH) are cofactors of energy-producing pathways present in all tissues, including the brain. In addition to its well-known role in energy metabolism and the maintenance of reduction-oxidation potential (NAD þ / NADH ratio), NAD þ also functions as a substrate with roles in gene transcription and repair, homeostasis, cell signaling, and the synchronization of metabolic pathway fluxes and metabolite levels via circadian oscillation (1) (2) (3) .
Despite the importance of NAD þ and NADH metabolism, until recently the available detection methods have been limited. Analysis of tissue extracts with various analytical methods, including NMR and MS, provide high sensitivity and specificity but are incompatible with in vivo studies on the human brain (4) (5) (6) . Autofluorescence of NADH coupled with confocal microscopy allows direct in vivo application but is complicated by limited tissue penetration and an inability to detect NAD þ (7). More recently, 31 P-MRS (8,9) and 1 H-MRS (10) have been proposed to noninvasively detect NAD þ and NADH in the human (9) and animal (8, 10) P-MR spectra are acquired with a pulse-acquire method and quantified with spectral fitting using NAD þ , NADH, adenosine triphosphate (ATP), phosphocreatine (PCr), and uridine diphosphate glucose (UDPG). The presence of UDPG is confirmed on rat brain and is demonstrated to be a significant contribution to the combined NAD þ plus NADH signal.
METHODS

General
MR measurements were performed on a 7T actively shielded, 68-cm-inner diameter MR magnet interfaced to a Direct Drive spectrometer (Agilent, Santa Clara, California, USA) and equipped with an asymmetric gradient system (Agilent) capable of switching 50 mT/m in 512 ms. The gradient system included a full set of thirdorder shim coils. 1 H-MR spectra were acquired with a single 80-mm-diameter surface coil tuned to the proton frequency (298.1 MHz), whereas 31 P-MR spectra were acquired with a single 80-mm-diameter surface coil tuned to 120.66 MHz. MR imaging, shimming, and 1 H decoupling were performed with a pair of 160-mmdiameter surface coils driven in quadrature (11) .
Six human subjects (men, n ¼ 5; women, n ¼ 1; age, 39 6 12 y) were scanned. All subjects participated in both 1 H-and 31 P-MR studies in two sessions separated by 2-10 days. All subjects were studied in accordance with Yale Institutional Review Board guidelines for research on human subjects.
In Vivo 1 H-NMR Spectroscopy
The detection of NAD þ by 1 H-MRS requires the use of short TE methods to minimize T 2 -related losses and the avoidance of water perturbation to eliminate saturation transfer effects on NAD þ . The sequence used previously on rat brain was composed of threedimensional (3D) LASER localization with a TE of 14 ms (10) . A direct translation to the human brain at 7T is not feasible, because limitations in maximum and average RF amplitudes would lengthen the LASER echo time to a minimum of 50 ms. Consequently, the pulse sequence was transformed into a onedimensional LASER method (TR/TE ¼ 1500/18 ms) selecting a 20-mm slice parallel to the surface coil (Fig.  1A) through the occipital cortex. Slice selection was achieved with a pair of 2-ms adiabatic full passage (hyperbolic secant modulation (12) , bandwidth ¼ 5.0 kHz) refocusing pulses. Spatial localization in the x and z directions are provided by the human head anatomy. The actual brain volume over all volunteers amounted to 96 6 12 mL as evaluated from multislice MR images. The brain volume was not corrected for the coil reception profile. The contribution from muscle was <5% on all volunteers. Significant lipid signal from skull and scalp tissue was present, but was inconsequential for NAD þ detection as lipids do not have NMR resonances beyond 5.5 ppm. Signal excitation was achieved with a minimum-phase 8.0 ms ShinnarLe Roux pulse (13) of 0.775 kHz bandwidth centered on 8.8 ppm. As water is minimally perturbed, no additional forms of water suppression were required.
1 H-MR spectra were acquired as 2048 complex points over a 12-kHz spectral width with number of acquisitions (NA) ¼ 640 for a total acquisition time of 16 min.
Absolute quantification of NAD þ requires an internal concentration reference. In addition to the NAA amide singlet at approximately 7.85 ppm, total creatine was also pursued as a concentration reference. Because the lipids signals from skull and scalp overwhelm the spectrum at TE ¼ 18 ms, creatine spectra were acquired at 50, 75, 100, 150, and 200 ms. After spectral fitting, the creatine intensity at TE ¼ 0 ms was obtained via extrapolation.
In Vivo 31 P-NMR Spectroscopy 31 P-NMR experiments were performed with a pulseacquire sequence (TR ¼ 5000 ms) in an unlocalized manner. The measured brain volume was estimated at 286 6 54 mL, not corrected for the coil reception profile. The square excitation pulse angle was adjusted to yield the highest PCr signal. 31 P-MR spectra were acquired as 2048 complex points over a 12-kHz spectral width with NA ¼ 192 for a total acquisition time of 16 min. For two subjects, 1 H decoupling was applied during signal acquisition. Decoupling was achieved using 8-ms adiabatic full passage pulses [HS4 modulation (14), 1.25 kHz bandwidth, gB 1 ¼ 0.3 kHz] incorporated into a 20-step supercycle designed to minimize decoupling sidebands (15) .
Animal Preparation
To confirm the presence and identity of UDPG, several in vivo and in vitro studies were performed on rat brains. Two Sprague-Dawley rats (205 6 11 g, mean 6 standard deviation) were prepared in accordance with the guidelines established by the Yale Animal Care and Use Committee. The animals were tracheotomized and . After all surgical procedures were completed, anesthesia was maintained by 0.3%-0.7% isoflurane. During NMR experiments, each animal's core temperature was measured with a rectal thermosensor and was maintained at 37 C 6 1 C by means of a heated water pad. After the in vivo studies, animals were euthanized by focused-beam microwave irradiation (16), after which the entire brain (without the olfactory bulb and cerebellum) was dissected. Rat brains were combined for a total weight of 2700 mg. Tissue extraction was initialized by adding 7.5 mL 3.0 M perchloric acid, followed by tissue homogenization in a bead homogenizer (Omni International, Kennesaw, Georgia, USA) for three cycles of 5 s. The sample was centrifuged for 30 min at 15,000 rpm, after which the supernatant was removed and neutralized with 10 M KOH. After centrifugation to remove the precipitated perchlorate salts, the supernatant containing the aqueous soluble NAD þ , NADH, and other metabolites was removed, lyophilized, and stored at À80
C for subsequent NMR analysis.
In Vitro NMR Spectroscopy
In vitro experiments were performed on a Bruker Avance III HD spectrometer (Bruker Instruments, Billerica, Massachusetts, USA) operating at 500.13 MHz for 1 H and equipped with a 5-mm triple resonance probe incorporating triple-axis gradient coils. The magnetic field homogeneity on each sample was optimized with an automated 3D field mapping algorithm capable of adjusting up to fifth-order spherical harmonics. Lyophilized brain extracts were resuspended in 700 mL H 2 O/D 2 O (15%/85%) containing 0.5 mM DSS-D6. Two-dimensional (2D) P-NMR visibility of NAD þ was studied on solutions of 1 mM NAD þ in 50 mM phosphate buffer (pH 7.2) in the absence or presence of alcohol dehydrogenase (ADH; EC1.1.1.1) at various temperatures. All chemicals were purchased from Sigma-Aldrich (St. Louis, Missouri, USA) and were used without further purification.
Data Processing
All FIDs were processed in off-line NMR processing software written in MATLAB 8.3 (MathWorks, Natick, Massachusetts, USA). Processing included time-domain B 0 correction using a water reference scan (17) ( 1 H-MRS only), zero-filling, exponential line broadening, Fourier transformation, phase correction, and chemical shift referencing (DSS-D6 at 0.00 ppm for 1 H-MRS and PCr at 0.00 ppm for 31 P-MRS). All spectra were quantified with a home-written spectral fitting program in MATLAB (18, 19) based on the LCModel algorithm (20 31 P-NMR signals were simulated with the density matrix formalism using homo-and heteronuclear scalar couplings determined in vitro at 500 MHz. For all spectra, a second-order polynomial baseline was included.
For absolute quantification of 1 H-MR spectra, total creatine and NAA are used as internal concentration references assuming concentrations of 9 and 10 mM, respectively. Quantification of 31 P-MR spectra was achieved with ATP as an internal concentration reference at 2.8 mM (9, 21, 22) . þ can be recognized at 9.33, 8.83, and 9.14 ppm, respectively. Due to the lower magnetic field, the NAD þ H4 resonance in Figure 1 is part of the rising edge of signals from adenosine (dominated by ATP) and other, unidentified compounds (23) (24) (25) . Repeating the measurement with conventional water suppression reduced the NAD þ signal several fold, in agreement with the studies performed on rat brain. Visual inspection of the spectra on different volunteers suggests a high reproducibility, which is confirmed by the absolute quantification results shown in Figure 2 . The spectral range between 7.0 and 9.5 ppm was adequately approximated with a spectral basis set of NAD þ , NAA, and eight singlet resonances. Using the NAA amide signal at approximately 7.85 ppm as a 10-mM internal concentration reference resulted in a NAD þ concentration of 107 6 28 mM. The Cramer-Rao lower bounds (CRLBs) for NAD þ and NAA were 7.3% 6 1.4% and 1.1% 6 0.6%, respectively. When using the total creatine methyl signal at 3.02 ppm (measured T 2 ¼ 92 6 7 ms) as a 9-mM internal concentration reference resulted in a NAD þ concentration of 103 6 18 mM. Figure 3 shows a typical 31 P-MR spectrum from human brain at 7T acquired in 16 min. In addition to the typical signals from phosphomono-and diesters, inorganic phosphate, phosphocreatine, and ATP, the spectrum holds a clear signal from NAD þ and NADH as an upfield shoulder on a-ATP. In addition, a signal at À9.83 ppm can be seen consistently in all subjects. The signal has been observed previously in rat brain extract (26) , rat brain in vivo (8) , and human brain (9, 22) and was tentatively assigned to UDPG. The high-resolution 31 P-NMR spectrum of UDPG 830 de Graaf et al.
RESULTS
indeed has a resonance at À9.83 ppm (Fig. 3C ), but because UDPG contains a diphosphate group (Fig. 3B ) it holds another, scalar-coupled resonance at À8.23 ppm ( 3 J PP ¼ 20 Hz). Because the second resonance partially overlaps with both NAD þ at À8.15 and À8.45 ppm and NADH at À8.10 ppm, it is imperative to confirm the identity of UDPG. A straightforward way to confirm the presence of a diphosphate group would be to perform a 2D 31 P- 31 P COSY experiment on the human brain in vivo. We were unable to obtain a 2D 31 P- 31 P COSY spectrum that demonstrates the presence of UDPG conclusively, presumably due to the low concentration and sensitivity of UDPG, as well as the short T 2 relaxation times. An attempt on rat brain in vivo at 9.4T also provided inconclusive results. The issue was resolved through the acquisition of a 31 P-31 P COSY spectrum on rat brain extract, as shown in Figure 4 . Figure 4A shows the pulseacquire Figure 4C shows a clear correlation between the signals at À9.83 ppm and À8.23 ppm, thereby proving conclusively that the signals are part of a scalar-coupled diphosphate group. Figure 5 shows quantification results for 31 P-MR spectra from the human brain at 7T. In Figure 5A , the signal at À9.83 ppm is treated as a singlet signal without a direct link to the NAD þ and NADH resonances around Chemical structure of uridine diphosphate glucose (UDPG) and (C) 31 P-MR spectrum acquired at 11.7T of UDPG. Phosphocreatine was added as an internal chemical shift reference at 0.00 ppm. GPC, glycerolphosphocholine; GPE, glycerolphosphoethanolamine; PC, phosphocholine; PE, phosphoethanolamine.
FIG. 2. Quantification of NAD
þ by 1 H-MRS. (A) Spectral fitting result of a 1 H-MR spectrum acquired from human brain at 7T. The top trace shows the experimental spectrum, similar to those in Figure 1 . The second trace shows the total spectral fit using a basis set of NAD þ , NAA, and eight undefined singlets. The spectral fitting quality is excellent as judged from the residual/difference between the experimental and fitted 1 H-MR spectra. The bottom two traces show the NAA and NAD þ contributions to the total spectral fit. (B) Absolute NAD þ concentrations in human brain when using NAA and creatine as internal concentration references.
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À8.1 to À8.5 ppm, as done previously (9, 22) . The spectral fit is excellent, providing reproducible concentrations for PCr (2989 6 8 mM), NAD þ (367 6 78 mM), NADH (159 6 34 mM), and UDPG (315 6 67 mM). The CRLBs on PCr, NAD þ , NADH, and UDPG were 0.3% 6 0.1%, 9.3% 6 4.0%, 24.0% 6 6.2%, and 5.7% 6 2.9%, respectively. Figure 5B shows the spectral fitting results when the signal at À9.83 ppm is treated as part of the UDPG doublet-of-doublets multiplet. The overall spectral fit quality is indistinguishable from Figure 5A , providing concentrations for PCr (3011 6 9 mM), NAD þ (312 6 65 mM), NADH (75 6 16 mM), and UDPG (339 6 99 mM). The CRLBs on PCr, NAD þ , NADH, and UDPG were 0.2% 6 0.1%, 8.8% 6 2.8%, 33.2% 6 6.0% and 5.2% 6 2.6%, respectively. Whereas the inclusion of UDPG does not visually affect the overall spectral fitting quality, it does cause a significant decrease in the NADH concentration, thereby leading to an increase in the NAD þ / NADH ratio from 2.4 6 0.6 to 4.2 6 0.9 (Fig. 5D) . The application of proton decoupling led to a 21%-46% increase in peak height for the phosphomono-and diester resonances (data not shown). However, no significant improvement in spectral resolution could be detected for the spectral region containing the NAD þ , NADH, and UDPG resonances. Figure 6 summarizes the central results of the in vitro NMR studies on the NMR visibility of NAD þ . Figure 6A holds the downfield spectral region of a pulse-acquire 1 H-NMR spectrum of 1 mM NAD þ in buffer solution (298 K) acquired with water presaturation. The NAD þ H2, H4, and H6 resonances are clearly visible at high spectral resolution. Upon addition of 0.5 mM ADH, the NAD þ resonances broaden and drop to a 15% NMR visibility as judged from the total integrated area of Figure 6B relative to that of Figure 6A . When water perturbation is minimized through frequency-selective excitation of the NAD þ H2-H6 spectral range, the NAD þ NMR visibility increases to 49% (Fig. 6C, 6D) . The 1 H-NMR visibility increased with increasing sample temperature. Figure 6E and 6F shows pulse-acquire 31 P-NMR spectra of NAD þ in the absence (Fig. 6E) and presence (Fig. 6F ) of 0.5 mM ADH. Similar to 1 H-NMR, the 31 P-NMR resonance lines broaden, but the NAD þ NMR visibility remains high at 86%.
DISCUSSION
Here it has been shown that NAD þ can be detected in the human brain in vivo at 7T by selective excitation eliminates the need for water suppression and 2) NAD þ H2 and H6 protons are completely free of spectral overlap. In addition, 1 H-based NAD þ detection can take advantage of the high intrinsic 1 H detection sensitivity as well as the multielement phasedarray receivers that are readily available on most MR systems. The ease of detection is offset by the partial NMR invisibility of NAD þ . NAD þ detection with 31 P-MRS has the advantage of providing a broad description of cerebral energy metabolism with the simultaneous detection of NAD þ , NADH, ATP, and PCr. 31 P-based detection of NAD þ is complicated by significant spectral overlap and the need for nonstandard (i.e., heteronuclear) MR hardware. The relatively low concentration of NAD þ requires relatively large volumes for both 1 H-and 31 P-NMR methods (90-300 mL). In addition, the requirement of avoiding water perturbation and short TEs further limit the localization options for 1 H-MRS in the human brain. The reduced NMR visibility of NAD þ is likely related to the complex interactions between NAD þ , water and a wide range of NAD þ binding enzymes, such as dehydrogenases. The in vitro studies shown in Figure 6 qualitatively reproduce the in vivo observations with a combination of NAD þ , water, and ADH. Whereas the in vivo situation is undeniably more complex, the simplified model system shows the ADH-mediated interaction between water and NAD þ (Fig. 6A, 6B ) and the partial NAD þ NMR visibility in the absence of water suppression (Fig. 6C, 6D) . The in vitro studies also revealed that NAD þ detection with 31 P-MRS is much less affected by ADH, yielding a significantly higher NMR visibility (Fig.  6E, 6F) . The 1 H-and 31 P-NMR in vitro results could be qualitatively explained by the NAD þ binding properties to ADH. The structure of horse liver ADH and its interaction with substrates and NAD þ have been studied in detail (27, 28) . The NAD þ nicotinamide group is positioned deep within the enzyme, forming strong hydrogen bonds interacting closely with the zinc active site. Even though the NAD þ phosphate groups do form several hydrogen bonds with ADH, they are positioned further from the active site with a presumably larger degree of rotational freedom.
The initial report on 1 H-MR-based NAD þ detection in the rat brain (10) did not reveal a significant NMR invisibility for NAD þ using the water signal as an internal concentration reference. The in vivo concentration (296 6 28 mM) was estimated at 83% of the concentration obtained from brain extract data (355 6 34 mM). Reanalysis of the rat brain data with spectral fitting using total The exact spectral signature of UDPG has essentially no effect on the quantification of PCr. However, modeling UDPG as a doublet signal decreases the NAD þ and especially the NADH concentrations, which has immediate consequences for (D) the redox potential (NAD þ /NADH).
creatine as a 10 mM internal concentration reference (instead of manual integration with water signal referencing) yielded a NAD þ concentration of 236 6 27 mM, representing a 66% NMR visibility.
The differences between human and rat brain may be explained by several factors. First, different main magnetic fields B 0 were used for data acquisition (human, 7T; rat, 11.7T). The line shape and line width of compounds involved in chemical equilibriums depend, among other parameters, on the chemical exchange rate relative to the Larmor frequency. As an increase in magnetic field B 0 shifts an equilibrium to the slow exchange limit, possibly providing less exchange-induced line broadening in the rat brain. Second, the pulse sequences used to acquire the signal were different with 3D LASER localization (TR/ TE ¼ 2000/14 ms) for rat brain and one-dimensional LASER localization (TR/TE ¼ 1500/18 ms) for human brain. Third, the composition of the detected volume was substantially different. Whereas signal on the rat brain in vivo was exclusively acquired from cortical gray matter, the slice acquired from human brain in vivo included approximately equal amounts of gray and white matter. In addition, a small contribution from muscles in the neck area is possible. Irrespective of the exact mechanisms and contributions, the partial 1 H-NMR visibility of NAD þ does limit the use of 1 H-MR-based NAD þ detection. Anecdotally, using identical acquisition methods as described for the brain, the 1 H-MR-based NAD þ detection method was unable to detect NAD þ on rat muscle in vivo, rat liver in situ and human muscle in vivo (data not shown). Because these tissues are known to contain significant amounts of NAD þ (29), these results imply a nearcomplete 1 H-NMR invisibility in these noncerebral tissues. NAD þ detection with 31 P-NMR appears to have a nearcomplete NMR visibility. This may be qualitatively explained by the difference in Larmor frequency between 1 H and 31 P and the different chemical position and binding characteristics of the nicotinamide protons and phosphorus atoms. However, unlike the 1 H-NMR method, NAD þ detection by 31 P-MRS is complicated by spectral overlap. In earlier reports (9) , the overlap between NAD þ , NADH, and a-ATP was recognized and used to obtain separate NAD þ and NADH levels, as well as the redox potential. We have demonstrated that uridine diphosphate glucose (UDPG) also contributes to the spectral overlap with NAD þ . UDPG has long been tentatively assigned as a single resonance at À9.83 ppm in 31 P-NMR spectra of the brain. We have shown conclusively that the 31 P-NMR spectrum of rat brain contains two scalarcoupled doublet signals at À8.23 and À9.83 ppm (Fig.  5C) . It is well known that the brain contains a variety of uridine diphosphate sugars (26) . Uridine diphospate glucose and galactose are the most abundant, with smaller contributions from uridine diphosphate mannose. Although these different UDP sugars can be detected separately with 31 P-NMR on brain extracts (26) , the resolution and sensitivity in vivo is insufficient to separate the individual contributions. As far as NAD þ and NADH detection is concerned, the exact nature of the UDP sugars is less relevant. The diphosphate group of all UDP sugars generates two signals at roughly À8.23 and À9.83 ppm. Although the presence of UDPG complicates the spectral overlap at the NAD þ /NADH 31 P chemical shift position further, it is still possible to reliably separate NAD þ , NADH, and UDPG provided that the proper prior knowledge on the spin systems is used. Inclusion of the UDPG doublet-of-doublets leads to a lower NADH level without significantly affecting the NAD þ level (Fig.  5) . As a result, the redox potential NAD þ /NADH significantly increased upon inclusion of UDPG.
Because the 31 P-MRS signal around À8.2 ppm is characterized by significant spectral overlap, any increase in spectral resolution is expected to be directly beneficial for the detection and separation of NAD þ and NADH. The application of proton decoupling to remove splitting due to heteronuclear 1 H-31 P scalar coupling is a potential method to achieve improved spectral resolution. Whereas the peak height of the phospho-mono-esters and diesters increased by 21%-46%, in agreement with previous studies, proton decoupling did not lead to an improved spectral resolution for the NAD þ /NADH/UDPG region. This is likely due to the fact that the spectral line width for NAD þ and NADH is dominated by T 
